DOI QR코드

DOI QR Code

Comparative studies of various transfection processes for the optimal luminescence signal analysis

최적의 luminescence 신호 분석을 위한 유전자 전달 방법의 비교연구

  • Park, Seohyun (Department of Biomedical Technology, Sangmyung University) ;
  • Lee, Sunghou (Department of Biomedical Technology, Sangmyung University)
  • 박서현 (상명대학교 의생명공학과) ;
  • 이승호 (상명대학교 의생명공학과)
  • Received : 2016.09.26
  • Accepted : 2016.11.10
  • Published : 2016.11.30

Abstract

By minimizing fluorescence interference phenomena, aequorin-based luminescence technology can provide a relatively sensitive detection platform with integration of $G{\alpha}16$ protein in order to track internal calcium mobilization by G protein-coupled receptors (GPCR). In this type of cell-based functional assay format, it is essential to optimize the transfection process of a receptor and $G{\alpha}16$ protein. For this study, corticotropin releasing factor receptor subtype 2(CRF2) was set as a model system to generate three stable cells with CRF2 and $G{\alpha}16$ in addition to transiently transfected cells under three different conditions. Agonist (sauvagine) and antagonist (K41498) responses in those cells were analyzed to develop the optimum transfection process. As a result, the effective signal ratio in the dose response experiments of sauvagine and K41498 were at least 10-fold higher (z'=0.77) in CRF2-$G{\alpha}16$ stable cells. For the transient transfection cells, stable expression of $G{\alpha}16$ prior to the CRF2 represented a two-fold higher signal (z'=0.84) than the other cases of transient transfection. In conclusion, for the utilization of transient transfection processes to develop a cell-based GPCR functional assay system, it is suggested to introduce various target receptors after stable expression of $G{\alpha}16$ protein.

형광 간섭 현상을 최소화시켜 상대적으로 민감한 측정이 가능한 aequorin기반 luminescence기술은 $G_{{\alpha}16}$ 단백질 도입을 통해 세포 내부의 칼슘 이동 신호를 감지하여 G 단백질 결합 수용체(G protein-coupled receptor, GPCR)의 기능 분석을 가능하게 하는 세포 기반 분석 기술로 수용체 및 G 단백질 유전자 전달의 최적화 과정이 필수적이다. 본 연구를 위해 corticotropin releasing factor receptor subtype 2(CRF2) 수용체를 모델 시스템으로 CRF2와 $G_{{\alpha}16}$ 단백질이 구축된 세 가지 안정화 세포주를 제작하였고, 이들을 이용한 서로 다른 세 가지 조건의 임시 발현 세포주에서 작용제(sauvagine)와 길항제(K41498)의 반응성을 분석하여 최적의 유전자 전달 방법을 도출하고자 하였다. 그 결과 sauvagine 및 K41498의 농도에 따른 반응에서 CRF2-$G_{{\alpha}16}$ 안정화 세포주가 임시 발현 세포주보다 10배 이상의 유효신호 비율을 나타내었고(z'=0.77) 임시 발현 세포주의 경우 $G_{{\alpha}16}$의 안정화 발현 이후에 CRF2를 전달하는 경우가 다른 임시 발현 조건보다 2배 이상 높은 효율을 보였다(z'=0.84). 따라서 임시 유전자 전달 기술을 GPCR 세포 기능 분석 시스템에 활용할 경우 $G_{{\alpha}16}$ 단백질에 대한 안정화 세포주를 우선적으로 구축하고, 목표하는 다양한 수용체들을 단계적으로 발현시키는 것이 최선의 방법이라 판단된다.

Acknowledgement

Supported by : 상명대학교

References

  1. J. Drews, "Drug discovery: a historical perspective", Science, 287(5460), pp. 1960-1964, 2000. DOI: https://doi.org/10.1126/science.287.5460.1960
  2. D. Zhang, Q. Zhao, B. Wu, "Structural studies of G protein-coupled receptors", Mol Cells, 38(10), pp. 836-842, 2015. DOI: https://doi.org/10.14348/molcells.2015.0263
  3. Y. W. Kim, H. S. Kim, S. Y. Kim, Y. H. Choi, S. H. Moh, Y. W. Cheon, "Development of scar improving materials using enkephalin derivatives", J Korea Acad Cooper Soc, 16(8), pp. 5336-5342, 2015. DOI: https://doi.org/10.5762/kais.2015.16.8.5336
  4. I. Y. Ku, S. J. Moon, K. H. Ka, M. K. Park, "Effects of carbenoxolone and P2X receptor antagonist combined therapy on oral neuropathic pain in rat", J Korea Acad Cooper Soc, 17(2), pp. 123-128, 2016.
  5. B. U. Ki, S. Y. Lee, "Role of Rab11 on membrane trafficking of rat vanilloid receptor, TRPV1, J Korea Acad Cooper Soc, 12(7), pp. 3096-3102, 2011.
  6. X. Wu, J. F. Glickman, B. R. Bowen, M. A. Sills, "Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists", J Biomol Screen, 8(4), pp. 391-392, 2003. DOI: https://doi.org/10.1177/1087057103256466
  7. T. K. Kim, J. H. Eberwine, "Mammalian cell transfection: the present and the future", Anal Bioanal Chem, 397(8), pp. 3173-3178, 2010. DOI: https://doi.org/10.1007/s00216-010-3821-6
  8. K. A. Paschos, E. Chouridou, M. Koureta, M. Lambropoulou, G. Kolios, E. Chatzaki, "The corticotropin releasing factor system in the liver: expression, actions and possible implications in hepatic physiology and pathology", Hormones (Athens), 12(2), pp. 236-245, 2013. DOI: https://doi.org/10.14310/horm.2002.1407
  9. E. D. Reinbold, J. L. Scholl, K. M. Oliver, M. J. Watt, G. L. Forster, "Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal", Neurosci Res, 89, pp. 37-43, 2014. DOI: https://doi.org/10.1016/j.neures.2014.08.010
  10. J. Sanders, C. Nemeroff, "The CRF system as a therapeutic target for neuropsychiatric disorders", Trends Pharmacol Sci, doi: 10.1016/j.tips.2016.09.004., 2016. (Epub ahead of print). DOI: https://doi.org/10.1016/j.tips.2016.09.004
  11. H. Noh, and S. Lee, "Optimization of the cryopreserved condition for utilization of GPCR frozen cells", J Korea Acad Cooper Soc, 16(2), pp. 1200-1206, 2015. DOI: https://doi.org/10.5762/kais.2015.16.2.1200
  12. H. Noh, S. Lee, "Development of an aequorin-based assay for the screening of corticotropin-releasing factor receptor antagonists", J Korea Acad Cooper Soc, 16(11), pp. 7575-7581, 2015. DOI: https://doi.org/10.5762/kais.2015.16.11.7575
  13. D. Prasher, R. O. McCann, M. J. Cormier, "Cloning and expression of the cDNA coding for aequorin, a bioluminescent calcium-binding protein", Biochem Biophys Res Commun, 126(3), pp. 1259-1268, 1985. DOI: https://doi.org/10.1016/0006-291X(85)90321-3
  14. D. Button, M. Brownstein, "Aequorin-expressing mammalian cell lines used to report Ca2+ mobilization", Cell Calcium, 14(9), pp. 663-671, 1993. DOI: https://doi.org/10.1016/0143-4160(93)90091-J
  15. C. W. Liaw, T. W. Lovenberg, G. Barry, T. Oltersdorf, D. E. Grigoriadis, E. B. de Souza, "Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid", Endocrinol, 137(1), pp. 72-77, 1996. DOI: https://doi.org/10.1210/en.137.1.72
  16. T. Riss, R. Moravec, A. Niles, "Selecting cell-based assays for drug discovery screening", Cell note, 13, pp. 16-21, 2005.
  17. J. H. Zhang, T. D. Chung, K. R. Oldenburg, "A simple statistical parameter for use in evaluation and validation of high throughput screening assays", J Biomol Screen, 4(2), pp. 67-73, 1999. DOI: https://doi.org/10.1177/108705719900400206
  18. D. Y. Oh, J. Y. Seong, "Physiological function of G protein-coupled receptors(GPCRs) and research trends for orphan GPCRs", J Korean Soc Endocrinol, 20(3), pp. 185-199, 2005. DOI: https://doi.org/10.3803/jkes.2005.20.3.185
  19. W. Thomsen, J. Frazer, D. Unett, "Functional assays for screening GPCR targets", Curr Opin Biotechnol, 16(6), pp. 655-665, 2005. DOI: https://doi.org/10.1016/j.copbio.2005.10.008
  20. P. J. Knight, T. A. Pfeifer, T. A. Grigliatti, "A functional assay for G-protein-coupled receptors using stably transformed insect tissue culture cell lines", Anal Biochem, 320(1), pp. 88-103, 2003. DOI: https://doi.org/10.1016/S0003-2697(03)00354-3
  21. T. Zhu, L. Y. Fang, X. Xie, "Development of a universal high-throughput calcium assay for G protein-coupled receptors with promiscuous G-protein $G_{{\alpha}15/16}$", Acta Pharmacol Sin, 29(4), pp. 507-516, 2008. DOI: https://doi.org/10.1111/j.1745-7254.2008.00775.x
  22. V. Menon, A. Ranganathn, V. H. Jorgensen, M. Sabio, C. T. Christoffersen, M. A. Uberti, K. A. Jones, P. S. Babu, "Development of an aequorin luminescence calcium assay for high-throughput screening using a plate reader, the lumilux", Assay Drug Dev Technol, 6(6), pp. 787-793, 2008. DOI: https://doi.org/10.1089/adt.2008.157
  23. D. Wu, A. Katz, C. H. Lee, M. I. Simon, "Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family", J Biol Chem, 267(36), pp. 25798-25802, 1992.
  24. B. R. Conkin, Z. Farfel, K. D. Lustig, D. Julius, H. R. Bourne, "Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha", Nature, 363(6426), pp. 274-276, 1993. DOI: https://doi.org/10.1038/363274a0
  25. A. Heydorn, R. J. Ward, R. Jorgensen, M. M. Rosenkilde, T. M. Frimurer, G. Milligan, E. Kostenis, "Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction", Mol Pharmacol, 66(2), pp. 250-259, 2004. DOI: https://doi.org/10.1124/mol.66.2.250
  26. P. Molinari, C. Ambrosio, D. Riitano, M. Sbraccia, M. C. Gro, T. Costa, "Promiscuous coupling at receptor-G alpha fusion proteins", J Biol Chem, 278(18), pp. 15778-15788, 2003. DOI: https://doi.org/10.1074/jbc.M300731200